8-22089270-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022749.7(FHIP2B):c.17G>A(p.Gly6Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000257 in 1,050,420 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022749.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHIP2B | NM_022749.7 | c.17G>A | p.Gly6Glu | missense_variant | 1/17 | ENST00000289921.8 | NP_073586.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHIP2B | ENST00000289921.8 | c.17G>A | p.Gly6Glu | missense_variant | 1/17 | 5 | NM_022749.7 | ENSP00000289921.6 |
Frequencies
GnomAD3 genomes AF: 0.0000203 AC: 3AN: 148032Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000266 AC: 24AN: 902280Hom.: 0 Cov.: 30 AF XY: 0.0000237 AC XY: 10AN XY: 421292
GnomAD4 genome AF: 0.0000203 AC: 3AN: 148140Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 72214
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 11, 2024 | The c.17G>A (p.G6E) alteration is located in exon 1 (coding exon 1) of the FAM160B2 gene. This alteration results from a G to A substitution at nucleotide position 17, causing the glycine (G) at amino acid position 6 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at